Anesthesiology
-
In a recent editorial, Kapur described perioperative nausea and vomiting as "the big 'little problem' following ambulatory surgery."257 Although the actual morbidity associated with nausea is relatively low in health outpatients, it should not be considered an unavoidable part of the perioperative experience. The availability of an emesis basin for every patient in the postanesthesia recovery unit is a reflection of the limited success with the available therapeutic techniques.257 There had been little change in the incidence of postoperative emesis since the introduction of halothane into clinical practice in 1956. However, newer anesthetic drugs (e.g. propofol) appear to have contributed to a recent decline in the incidence of emesis. ⋯ Research into the mechanisms of this common postoperative complication may help in improving the management of emetic sequelae in the future. As suggested in a recent editorial, improvement in antiemetic therapy could have a major impact for surgical patients, particularly after ambulatory surgery. Patients as well as those involved in their postoperative care look forward to a time when the routine offering of an emesis basin after surgery becomes a historical practice.
-
Comparative Study
A comparison in a lung model of low- and high-flow regulators for transtracheal jet ventilation.
There is widespread agreement that transtracheal jet ventilation (TTJV) using a percutaneously inserted intravenous (iv) catheter through the cricothyroid membrane is a simple, quick, relatively safe, and extremely effective treatment for the situation in which neither ventilation nor intubation can be achieved. No study has reported whether a low-flow pressure-reducing regulator (LFR) can provide enough driving pressure and flow under a variety of clinical circumstances for adequate TTJV. We determined, using a high-flow regulator (HFR) as our control, the tidal volume (VT) (measured by integrating a pneumotachograph signal) that a LFR could deliver via a Carden jet injector through 14- and 20-G iv catheters initially at an inspiratory:expiratory ratio (I:E) = 1:1 (unit of time = 1 s) in a mechanical model that had varying lung compliance (Cset, 10-100 ml/cmH2O) and airway diameters (proximal trachea 15.0, 4.5, or 3.0 mm ID and distal mainstem bronchi 9.0 or 4.5 mm ID). ⋯ Decreasing Cset (with the largest airway diameter) and decreasing airway diameter (at Cset = 50 ml/cmH2O) over the full range studied resulted in approximately a 45-80% decrease in VT for all iv catheter/regulator combinations. Increasing Cset and narrowing airway diameter over the full range studied resulted in a progressive increase in end-expiratory volume (EEV) for all iv catheter/regulator combinations. The I:E ratio was also varied from 1:3 to 3:1 (unit of time = 1 s) using the 14-G catheter at Cset = 50 ml/cmH2O with both regulators at the extremes of the proximal tracheal diameters (15.0 and 3.0 mm ID), and we found that jet ventilation through a proximal tracheal diameter of 3.0 mm with the HFR at I:E ratios = 1:1 and 3:1, EEV exceeded the capacity of the mechanical lung (4,000 ml).(ABSTRACT TRUNCATED AT 400 WORDS)
-
Randomized Controlled Trial Clinical Trial
The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification.
The role of desmopressin acetate in attenuating blood loss and reducing homologous blood component therapy after cardiopulmonary bypass is unclear. The purpose of this investigation was to identify a subgroup of patients that may benefit from desmopressin acetate therapy. One hundred fifteen patients completed a prospective randomized double-blind, placebo-controlled trial designed to evaluate the effect of desmopressin acetate (0.3 microgram.kg-1) on mediastinal chest tube drainage after elective coronary artery bypass grafting surgery in patients with normal and abnormal platelet-fibrinogen function as diagnosed by the maximal amplitude (MA) on thromboelastographic (TEG) evaluation. ⋯ During the first 24 h after cardiopulmonary bypass, the placebo-treated patients in group 2 had significantly greater mediastinal chest tube drainage when compared to placebo patients in group 1 (1,352.6 +/- 773.1 ml vs. 865.3 +/- 384.4 ml, P = 0.002). In addition to increases in blood loss, group 2 placebo patients also were administered an increased number of blood products (P less than 0.05). The desmopressin-treated patients in group 2 neither experienced increased mediastinal chest tube drainage nor received increased amounts of homologous blood products when compared to those in group 1.(ABSTRACT TRUNCATED AT 250 WORDS)
-
Randomized Controlled Trial Clinical Trial
Fifty percent nitrous oxide does not increase the risk of venous air embolism in neurosurgical patients operated upon in the sitting position.
Although nitrous oxide (N2O) should theoretically increase the severity of venous air embolism (VAE), data confirming this hazard in clinical situations are not available. The effect of 50% N2O on the incidence and severity of VAE and on the emergence time from anesthesia was evaluated in 300 neurosurgical patients operated upon while in the sitting position. Of these, 110 patients underwent craniectomy for posterior fossa pathology and 190 patients underwent cervical spine surgery (CSS). ⋯ Emergence time was significantly longer in the craniectomy group than in the CSS group (5 vs. 1 min, respectively; P less than 0.001). Within the craniectomy group, the incidence of Doppler-detected VAE was significantly less in patients with previous surgery at the operative site (21%) compared to patients without previous surgery at the operative site (47%). Postoperatively, no complications could be related to the use of N2O or directly attributed to the occurrence of VAE.(ABSTRACT TRUNCATED AT 400 WORDS)
-
Randomized Controlled Trial Clinical Trial
The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade.
To determine whether the dose of atropine affects the rate of neostigmine-induced recovery from vecuronium-induced neuromuscular blockade, the authors monitored isometric adductor pollicis mechanical activity in 36 anesthetized (thiopental, fentanyl, nitrous oxide) adult patients (ASA physical status 1 or 2). Once surgery was completed and twitch height had spontaneously regained 25% of its initial value, the patients were randomly allocated into three groups (A10, A15, A20; n = 12 in each group) according to the dose of atropine (10, 15, or 20 micrograms/kg) that was mixed with 40 micrograms/kg neostigmine. Twitch height, train-of-four, and 50- and 100-Hz tetanic fade were recorded for 15 min after the administration of the reversal agents. ⋯ Fifteen minutes after reversal, fade in response to 100-Hz tetanus was statistically greater in the A10 group than in the two other groups (70% +/- 3% of control versus 84% +/- 4% and 81% +/- 2%) (mean +/- SEM, P less than 0.05). The present results demonstrate that larger doses of atropine facilitate neostigmine's reversal of vecuronium neuromuscular blockade. The clinical implications of the differences observed in this study remain to be determined.